Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has relapsed or proven refractory to previous treatments. In addition to its lead candidate, the company's robust pipeline features several other therapeutic assets: CNTY-103: A CAR-iNK candidate aimed at CD133 + EGFR for recurrent glioblastoma. CNTY-102: A CAR-iT therapy targeting CD19 + CD79b, intended for relapsed or refractory B-cell lymphoma and other B-cell cancers. CNTY-104: A multi-specific CAR-iT or CAR-iNK candidate in development for acute myeloid leukemia. CNTY-106: Another multi-specific CAR-iNK or CAR-iT candidate for multiple myeloma. Established in 2018, Century Therapeutics, Inc. is based in Philadelphia, Pennsylvania.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Century Therapeutics, Inc.
NASDAQ:IPSCHealthcare · Biotechnology
+0.68%$1.47
AH$1.47+0.00%vs close
Mkt Cap$266.18M
Float175.15M
O/S181.08M
Vol
$ Vol
RVOL
Inst Own87.3%
Earnings
Dilution
Financials Summary
Revenue$109.16M
Net Income-$9.58M
Total Assets$223.7M
Free Cash Flow-$104.72M
Debt & Equity
Debt 22%
Equity 78%
Total Debt$43.56M
Total Equity$158.94M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in IPSC's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$223.7M
Liabilities$64.77M
Accounts Receivable$667K
Accounts Payable$4.77M
Inventory$0
PP&E (Net)$66.17M
Goodwill$0
Intangible Assets$34.2M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $109.16M | $6.59M | $2.23M | $5.2M | $0 | $0 | $0 |
| YoY Growth | 1556.8% | 194.8% | -57.0% | - | - | - | - |
| Cost of Revenue | $13.1M | $0 | $0 | $0 | $4.58M | $1.75M | $249K |
| Gross Profit | $96.06M | $6.59M | $2.23M | $5.2M | -$4.58M | -$1.75M | -$249K |
| Gross Margin | 88.0% | 100.0% | 100.0% | 100.0% | - | - | - |
| Research and Development | $95.67M | $107.24M | $92.71M | $97.17M | $75.65M | $39.68M | $14.27M |
| Selling, General, and Administrative | $24M | $33.16M | $34.71M | $31.86M | $14.65M | $7.74M | $5.52M |
| Other | -$8.57M | $4.33M | $21.36M | $10M | $0 | $0 | $0 |
| Total Operating Expenses | $111.1M | $144.73M | $148.78M | $139.03M | $90.3M | $47.42M | $19.78M |
| Operating Income (EBIT) | -$15.04M | -$138.14M | -$146.55M | -$133.83M | -$94.88M | -$49.18M | -$20.03M |
| Operating Margin | -13.8% | -2096.5% | -6556.9% | -2574.2% | - | - | - |
| Interest Expense | $0 | $0 | $540K | $0 | $1.27M | $381K | $0 |
| Interest Income | $7.35M | $13.01M | $12.68M | $2.99M | $898K | $704K | $1.21M |
| Other Income (Expense) | $5.39M | $13.36M | $11.75M | $2.99M | -$898K | -$4.4M | -$224.74M |
| Income Before Tax (EBT) | -$9.65M | -$124.78M | -$134.79M | -$130.84M | -$95.78M | -$53.58M | -$244.77M |
| Income Tax Expense | -$68K | $1.79M | $1.88M | $91K | $43K | $0 | $0 |
| Net Income | -$9.58M | -$126.57M | -$136.67M | -$130.93M | -$95.82M | -$53.58M | -$244.77M |
| Net Income Margin | -8.8% | -1920.9% | -6115.1% | -2518.4% | - | - | - |
| Supplementary Data | |||||||
| EPS | -0.11 | -1.61 | -2.30 | -2.27 | -1.74 | -1.00 | -4.49 |
| Diluted EPS | -0.11 | -1.61 | -2.30 | -2.27 | -1.74 | -1.00 | -4.49 |
| Weighted Average OS | 86.56M | 78.65M | 59.31M | 57.76M | 55.01M | 54.82M | 54.82M |
| EBITDA | $3.45M | -$111.47M | -$121.21M | -$121.2M | -$90.76M | -$51.79M | -$244.52M |
| EBITDA Margin | 3.2% | -1691.8% | -5423.2% | -2331.2% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $61.85M | $58.44M | $47.32M | $84.27M | $56.45M | $27.21M | $44.06M |
| Short-Term Investments | $55.26M | $130.85M | $125.41M | $231.23M | $166.43M | $48.54M | $37.48M |
| Cash and Short-Term Investments | $117.11M | $189.29M | $172.74M | $315.5M | $222.88M | $75.75M | $81.54M |
| Accounts Receivable | $667K | $1.52M | $665K | $780K | $250K | $908K | $123K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.74M | $860K | $1.78M | $462K | $2.79M | $1.8M | $320K |
| Total Current Assets | $120.77M | $194.05M | $176.99M | $319.72M | $228.15M | $78.8M | $84.12M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $66.17M | $90.85M | $92.08M | $111.73M | $69.82M | $24.78M | $2.49M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $34.2M | $34.2M | $0 | $0 | $0 | $9.39M | $0 |
| Long-Term Investments | $2.36M | $30.82M | $91.08M | $51.85M | $135.91M | $1.05M | $4.08M |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $211K | $3.3M | $541K | $3.24M | $3.49M | -$7.24M | $206K |
| Total Long-Term Assets | $102.94M | $159.16M | $183.7M | $166.82M | $209.22M | $27.98M | $6.77M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $223.7M | $353.22M | $360.69M | $486.54M | $437.38M | $106.78M | $90.9M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $4.77M | $3.08M | $2.74M | $5.45M | $7.6M | $8.08M | $1.55M |
| Short-Term Debt | $0 | $0 | $1.51M | $6.5M | $1.04M | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $109.16M | $4.37M | $7.15M | $0 | $0 | $0 |
| Other Current Liabilities | $3.78M | $82K | $2.72M | $3.17M | $1.08M | $52K | $53K |
| Total Current Liabilities | $20.23M | $129.78M | $17.85M | $29.82M | $15.65M | $12.11M | $2.99M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $3.74M | $8.9M | $9.64M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $111.38M | $110.83M | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $4.3M | $4.37M | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $8.74M | $56K | $718K | $2.02M | $179.76M | $179.76M |
| Total Long-Term Liabilities | $44.54M | $62.07M | $158.09M | $153.99M | $25.48M | $201.08M | $179.76M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $64.77M | $191.85M | $175.94M | $183.81M | $41.14M | $213.19M | $182.75M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $9K | $9K | $6K | $6K | $5K | $1K | $1K |
| Retained Earnings | -$791.92M | -$782.34M | -$655.77M | -$519.1M | -$388.17M | -$292.34M | -$238.77M |
| Comprehensive Income & Other | $30K | $324K | $108K | -$2.46M | -$650K | -$3K | -$3K |
| Other Stockholders' Equity | $950.84M | $943.69M | $840.51M | $821.83M | $784.4M | $185.93M | $146.91M |
| Total Equity | $158.94M | $161.36M | $184.75M | $302.74M | $396.24M | -$106.41M | -$91.86M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $223.7M | $353.22M | $360.69M | $486.54M | $437.38M | $106.78M | $90.9M |
| Supplementary Data | |||||||
| Total Debt | $43.56M | $53.83M | $48.17M | $49.41M | $25.12M | $21.55M | $0 |
| Net Debt | -$18.29M | -$4.61M | $847K | -$34.85M | -$31.33M | -$5.66M | -$44.06M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$9.58M | -$126.57M | -$136.67M | -$130.93M | -$95.82M | -$53.58M | -$244.77M |
| Depreciation & Amortization | $13.1M | $13.3M | $13.04M | $8.44M | $3.75M | $1.4M | $249K |
| Deferred Income Tax | -$73K | $870K | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $6.84M | $12.69M | $14.62M | $10.67M | $4.66M | $876K | $147K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.56M | -$1.47M | -$2.36M | -$4.79M | -$1.85M | $2.06M | $1.23M |
| Other Working Capital | -$116.11M | -$7.81M | $11.74M | $128.73M | -$949K | $2.8M | $1.03M |
| Total Working Capital Change | -$114.55M | -$9.28M | $9.38M | $123.94M | -$2.8M | $4.86M | $2.26M |
| Other Non-Cash Items | $389K | -$1.15M | $11.28M | $1.93M | $1.21M | $5.17M | $225.95M |
| Net Cash from Operating | -$103.88M | -$110.14M | -$88.35M | $14.05M | -$89M | -$41.27M | -$16.17M |
| Investing Activities | |||||||
| Capital Expenditures | -$848K | -$154K | -$13.74M | -$30.6M | -$44.97M | -$9.82M | -$2.46M |
| Acquisitions | $0 | -$9.61M | $0 | -$238.22M | $0 | $0 | $0 |
| Purchases of Investments | -$51.17M | -$119.55M | -$209.03M | -$254M | -$330.03M | -$49.86M | -$41.54M |
| Sales of Investments | -$51.17M | $176.79M | $283.9M | $271.48M | $76.67M | $41.65M | $0 |
| Other Investing Activities | $210.7M | $0 | $0 | $238.22M | $0 | -$4.72M | $24.17M |
| Net Cash from Investing | $107.5M | $47.48M | $61.13M | -$13.13M | -$298.34M | -$22.76M | -$19.83M |
| Financing Activities | |||||||
| Debt Repaid | - | - | $10.24M | - | - | -$9.73M | - |
| Common Stock Issuance | $173K | $74.56M | $516K | $27.16M | $221.62M | $0 | $74.84M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $36.53M | $37.96M | $0 |
| Net Cash from Financing | $173K | $74.56M | -$9.72M | $27.16M | $417.77M | $47.69M | $74.84M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $3.8M | $11.91M | -$36.94M | $28.08M | $30.43M | -$16.34M | $38.84M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$103.88M | -$110.14M | -$88.35M | $14.05M | -$89M | -$41.27M | -$16.17M |
| Capital Expenditure | -$848K | -$154K | -$13.74M | -$30.6M | -$44.97M | -$9.82M | -$2.46M |
| Free Cash Flow | -$104.72M | -$110.29M | -$102.08M | -$16.55M | -$133.97M | -$51.09M | -$18.63M |
| Cash at Beginning | $61.21M | $49.3M | $86.24M | $58.16M | $27.73M | $44.06M | $31.42M |
| Cash at End | $65.01M | $61.21M | $49.3M | $86.24M | $58.16M | $27.73M | $70.26M |